IGF1 and acromegaly: The Acro-TSQ is a patient-centered tool for assessing factors related to quality of life and treatment perception, and, when used in conjunction with clinical measures of disease activity like IGF-1, GH, and AIS, will provide a comprehensive picture of the impact of acromegaly and its treatment on patients’ lives.